Skip to content

InterCure Stock: Pot Stock Has 175% Upside Potential

Cannabis stocks have been taking a beating lately, but that isn’t because cannabis sales haven’t been robust globally. It’s because the potential federal U.S. legalization of marijuana has been bogged down, and investors are only so patient.

The U.S. and Canada are by far the largest markets for legal pot, but Israel has been a pioneer in medical cannabis research and development for over 50 years. In addition to legalizing medical marijuana for a wide variety of treatments, Israel has decriminalized the use of cannabis for those over the age of 18 when used in private.

One great way to play Israel’s burgeoning marijuana industry is through InterCure Ltd (NASDAQ:INCR), which does business as Canndoc. It’s the most profitable and fastest-growing cannabis company outside North America.

INCR Stock Has Bright Outlook

This post appeared first on Profit Confidential.